Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Alclometasone dipropionate cream
Alclometasone dipropionate · 1 trial · 4 indications
Incorrect duration of use was defined as the use of study medication for more than 7 consecutive days and/or more than three times in a day. Participants were asked the reasons of doing so and they were allowed to select multiple reasons also, if applicable.
| Arm | Type | Description |
|---|---|---|
| Alclometasone dipropionate cream | EXPERIMENTAL | Alclometasone dipropionate cream 0.05% will be applied by the participants topically on the affected areas per label instructions for 14 days. |
| Name | Type | Description |
|---|---|---|
| Alclometasone dipropionate cream | DRUG | Alclometasone dipropionate cream 0.05% (15 g) |
Inclusion Criteria: * Age: At least 12 years of age. * Condition: Currently experiencing itch associated with one of the following skin conditions: * psoriasis or eczema, * minor skin conditions such as those caused by poison ivy, oak, or sumac, insect bites, or use of cosmetics, soaps, deterg...
Alclometasone dipropionate is a small molecule drug being developed by GSK plc for eczema, an inflammatory skin condition. It is also known as alclometasone dipropionate cream. The drug is in Phase 2 clinical development and has been studied in a completed trial that enrolled 310 participants aged 12 years and older.
Alclometasone dipropionate is being studied for eczema, which falls within the immunology therapeutic area. A completed Phase 2 trial also listed allergy symptoms, psoriasis, and itch among the conditions evaluated. The drug has not been established as an approved treatment for these conditions based on the available development information.
Alclometasone dipropionate is developed by GSK plc, which trades under the ticker GSK. The company is the sponsor behind the clinical program evaluating the drug in eczema and related skin conditions.
Alclometasone dipropionate is in Phase 2 clinical development. One Phase 2 trial has been completed, and no trials are currently active. The completed study enrolled 310 participants and evaluated product duration of use experience with alclometasone dipropionate cream.
Alclometasone dipropionate has been evaluated in one completed Phase 2 trial, NCT02075632, titled Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream. The trial enrolled 310 participants aged 12 years and older and covered eczema, allergy symptoms, psoriasis, and itch. It was an uncontrolled study.
Yes, alclometasone dipropionate cream is another name for alclometasone dipropionate. The cream formulation is the version evaluated in the completed Phase 2 trial NCT02075632, which studied product duration of use experience in participants with eczema and related skin conditions.